Investor's Business Daily on MSN
Google, IBD Stock Of The Day, Closing In On AI Winner's Circle
Google stock has gained over 34% in 2025 and trades near its all-time high as more investors view the company as an AI winner ...
Investor's Business Daily on MSN
IBD Rating Upgrades: KB Financial Group ADR Shows Improved Price Strength
A Relative Strength Rating upgrade for KB Financial Group ADR shows improving technical performance. Will it continue?
ABBV leans on booming Skyrizi and Rinvoq-driven sales to sustain growth and counter Humira's decline as Q3 results approach.
Nasdaq provides pre-market quotes of stock trades from 4:00 A.M. EST to 9:29 A.M. EST. After Hours participation from Market Makers and ECNs is strictly voluntary. Investors who anticipate trading ...
Herbicides have been linked to inflamatory bowel disease. The incidence of inflamatory bowel disease is on the rise. New medications from AbbVie show signs of promise. Now that I'm firmly seated on ...
Immunai collected a hefty $215 million series B round back in 2021 after raising $60 million through a series A earlier that same year. Those funds have helped the company stretch its reach from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results